New knowledge on EphB signalling may improve treatment of intestinal cancers

... did not interfere with the tumour suppressor function of EphB receptors", said Jonas Frisen, Professor of Stem Cell Research at Karolinska Institutet, who supervised the study." "Our work may have important clinical implications, as Imatinib is a ...

http://ift.tt/1ChdPtt